All major technical indicators are bearish and aligned: price below the 10 EMA, 50 SMA, 200 SMA, and VWMA simultaneously; 50 SMA has rolled over from $155 to $138 over four months; 200 SMA has acted as resistance on every rally attempt since May 2026; MACD histogram is expanding negative at -0.41.

• Price below 10 EMA, 50 SMA, 200 SMA, and VWMA simultaneously
• 50 SMA rolled over from $155 to $138
• 200 SMA resistance on every rally attempt since May 2026
• MACD histogram expanding negative at -0.41
• Lower Bollinger band is sloping downward, so the support level itself is migrating lower
• Sep 9 volume 7.37M, Sep 11 volume 8.77M, Sep 14 volume 10.09M
• Sep 14 intraday range 1.4% bearish span: open at $138, close at $136.34, near the low

↩ rebuts: “Bull claim that 20% drawdown from $171.48 is a 'clearance rack' opportunity and Bollinger band taps produce reliable lows”

Q2 2026 revenue growth of 6.4% YoY is almost entirely price-driven, not volume-driven; management called the home market 'broken'; price-driven growth has a shelf life as consumer pushback is real and private-label penetration is accelerating.

• Q2 2026 revenue grew 6.4% YoY
• Management literally called the home market 'broken' in their summer earnings call
• PEP has been aggressively raising prices for two years

↩ rebuts: “Bull claim of 'accelerating fundamentals' and underlying volume strength”

The '137% EPS growth' claim is an accounting artifact—Q2 2025 normalized EPS was around $1.95-2.00 (after stripping impairment distortion), making Q2 2026 EPS of $2.18 roughly 9-12% underlying growth, not triple-digit; 2025 net income was $8.24B, down from $9.58B in 2024.

• Q2 2025 normalized EPS around $1.95-2.00
• Q2 2026 EPS of $2.18
• 2025 net income $8.24 billion, down from $9.58 billion in 2024
• Forward EPS of $8.98 vs comparable base of $7.63 (artificially depressed by impairment)
• Normalized forward EPS growth more like 8-10%
• PEG ratio closer to 2.0 than 1.4

↩ rebuts: “Bull's headline 137% EPS growth figure and acceleration thesis”

FCF coverage is razor-thin with zero buffer: $7.83B FCF vs ~$7.8B in annual dividends; a 5% revenue softening, commodity cost spike, or $1B seasonal working capital build would make coverage go negative; GAAP earnings don't pay dividends—cash does.

• $7.83B FCF vs ~$7.8B in annual dividends
• Zero FCF buffer for error
• Q1 working capital absorbed another $1B seasonal build

↩ rebuts: “Bull claim that 75% net income coverage provides 'ample cushion'”

CapEx declined from $5.52B to $4.42B—raising serious questions about whether PEP is underinvesting in its productive base; when a consumer staples company cuts capex 20% over two years, future volume capacity is constrained.

• CapEx declined from $5.52B to $4.42B
• 20% capex reduction over two years

↩ rebuts: “Bull's positive spin on declining CapEx as 'efficiency'”

PEP's 4.34% yield sits at a 66-basis-point deficit to the 10Y Treasury at 5%; inflation re-acceleration is NOT the consensus (prediction markets price 94% probability of no Fed cuts in 2026); the 10Y at 5% reflects contained inflation expectations.

• PEP's 4.34% dividend yield
• 10Y Treasury at 5%
• 66-basis-point deficit to the 10Y Treasury
• 94% probability of no Fed cuts in 2026 priced by prediction markets

↩ rebuts: “Bull claim that growing dividend 'crushes' Treasuries in real-return terms if inflation re-accelerates”

KO's outperformance is not 'priced in' convergence—it reflects structural competitive dynamics: KO has strongest volume growth in nearly two decades, raised guidance, and is gaining pricing power in c-stores; PEP lost share in c-stores (highest-margin channel) and management admitted the home market is broken—this is a profit pool migration, not a temporary blip.

• KO +29% YTD
• KO's strongest volume growth in nearly two decades
• KO raised guidance in their most recent quarter
• PEP lost share in c-stores—highest-margin channel in beverage distribution
• Management literally admitted the home market is broken

↩ rebuts: “Bull claim that KO-vs-PEP valuation gap 'marks the optimal entry into the laggard' and signals institutional rotation”

Institutional recommendations for PEP come from income-focused publications targeting yield-starved retirees, not performance-oriented institutional buyers; the real money has voted into KO, not PEP.

• 5+ explicit buy recommendations
• These are written by income-focused publications targeting yield-starved retirees
• Real money (pension funds, hedge funds, asset managers) has voted into KO, not PEP

↩ rebuts: “Bull claim that institutional recommendations signal rotation thesis”

GLP-1 drugs (Ozempic, Wegovy, Mounjaro) are structurally suppressing snack food consumption—a multi-year behavioral shift with millions of new users annually; PEP's snack portfolio (Doritos, Lay's, Cheetos) is precisely the high-calorie, hyper-palatable category that GLP-1 users avoid; Siete Foods acquisition is a culturally-trendy brand bought at the top of the health-food hype cycle with integration risk; NotCo JV selling Brazil assets is a strategic retreat.

• Half of PEP operating profit is from Frito-Lay/snacks
• Millions of new GLP-1 users annually with expanding insurance coverage
• Siete Foods acquisition at premium at top of health-food hype cycle
• NotCo JV selling Brazil assets

↩ rebuts: “Bull's positioning of Frito-Lay as structural defense and Siete Foods as growth vector”

'Dirty soda' is a Utah-centric, regionally-concentrated trend with limited national scalability; the energy category is dominated by Red Bull and Monster (which KO has a meaningful stake in); PEP doesn't have a credible national energy play; c-store share losses suggest innovation isn't moving the needle.

• 'Dirty soda' is Utah-centric and regionally concentrated
• Energy category dominated by Red Bull and Monster
• KO has meaningful stake in Monster
• PEP's 'energy adjacencies' are mostly partnerships and minority stakes, not owned brands
• C-store share losses

↩ rebuts: “Bull's positioning of Mountain Dew and Mug Root Beer RTDs as innovation momentum and energy adjacencies as credible growth”

PEP's 0.36 beta means there's no flight-to-safety bid for PEP if the macro is muddling through (the consensus); the 10Y at 5% is a multiple compression event for the entire duration-heavy equity complex; P/E of 17.87x is at the high end of historical range for a defensive name with 8-10% underlying growth—room for compression, especially if 10Y pushes toward 5.5%.

• PEP beta of 0.36
• Recession probability at 10% (not the consensus)
• 10Y at 5%
• PEP P/E of 17.87x at high end of historical range for defensive name
• 10Y at 5.5% would compress the multiple further

↩ rebuts: “Bull claim that Fed-on-hold, recession-at-10% backdrop favors defensives”

Downside target of $130.55 is only 4% below current but $130 is just the July intraday low—below that there is no historical support, PEP has NEVER traded at $125 or below in the past decade; upside to $148-152 requires price to reclaim the 50 SMA ($138), VWMA ($138.47), and 200 SMA ($148.58)—all overhead resistance; the technical report is explicit that every rally since has stalled at or below the 200 SMA.

• Downside target $130.55
• Only 4% below current
• $130 is just the July intraday low
• PEP has NEVER traded at $125 or below in the past decade
• 50 SMA at $138
• VWMA at $138.47
• 200 SMA at $148.58
• Every rally since has stalled at or below the 200 SMA

↩ rebuts: “Bull's asymmetric risk-reward framework with $130.55 downside and $148-152 upside”

Q3 earnings as a binary catalyst cuts both ways—if PEP guides below consensus on Frito-Lay volumes, admits further c-store share erosion, or signals GLP-1 volume pressure, the stock breaks $130, not $148.

• Q3 earnings as potential catalyst

↩ rebuts: “Bull's reliance on Q3 earnings as positive binary catalyst”

Regulatory risks accelerating: RFK Jr.'s anti-sugar campaign gaining mainstream traction; Surgeon General nominee disclosed holdings in cola/tobacco (regulatory signal); sugary drink labeling, advertising restrictions to children, or excise taxes could directly hit PEP volumes.

• RFK Jr.'s anti-sugar campaign gaining mainstream traction
• Surgeon General nominee disclosed holdings in cola/tobacco

↩ rebuts: “Bull's dismissal of regulatory concerns”

FX translation risk: strong dollar compresses reported revenue and earnings on significant international operations; dollar has been bid on higher-for-longer Fed stance.

• Significant international operations
• Dollar bid on higher-for-longer Fed stance

Acquisition indigestion: Pioneer Foods, SodaStream, Siete Foods—multiple large deals in recent years mean integration risk, brand cannibalization, and goodwill impairment exposure (recall the 2025 impairment charge).

• Pioneer Foods, SodaStream, Siete Foods—multiple large deals
• 2025 impairment charge